Conference abstractPublished 6 Nov 2017

Comparative proteomic analysis of affected and non-affected areas of systemic sclerosis skin biopsies

Authors: Paraskevi Chairta, Paschalis Nicolaou, Kleitos Sokratous, George M Spyrou, Christine Galant, Frederic Houssiau, Bernard R Lauwerys, Kyproula Christodoulou

Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus; UniversitÃ?Â?Ã?© catholique de Louvain, Bruxelles, Belgium

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Systemic sclerosis (SSc) is an autoimmune rheumatic disease characterized by vasculopathy, inflammation and fibrosis. It is a complex and heterogeneous disease, as many organs of the body may be affected and symptoms vary among individuals. As the aetiology and pathogenesis of the disease are currently unclear, its prognosis and diagnosis are challenging and thus up to date there is no cure for SSc. Therefore, the purpose of this study is to discover specific proteomic biomarkers gaining insights into the mechanisms implicated in SSc pathogenesis and facilitating the early prognosis, more accurate diagnosis and therapeutic targeting of the disease. Methodology & Theoretical Orientation: Human biopsies were obtained from affected and non-affected skin areas of SSc patients and have been classified based on histological criteria. Proteins were extracted from human skin biopsies, purified, reduced, alkylated and digested with trypsin. Purified peptides were analyzed on a Waters SYNAPT G2Si HDMS instrument operated in ion mobility mode using a UDMSE approach. Data were processed by the Progenesis QI and functional annotation analysis performed using multiple bioinformatics resources. Findings: Proteomic analysis led to identification and quantification of more than 1500 differentially expressed proteins. Differential expression of approximately 1000 out of these proteins including interferons and interleukins, have statistically significant fold Change of Ã?¢Ã?Â?Ã?¥1.5 or Ã?¢Ã?Â?Ã?¤0.667. Further pathway analyses showed that the identified dysregulated proteins were involved in multiple pathways including, antigen processing and presentation and complement pathway, which is known to be associated with autoimmune diseases. Conclusion & Significance: Using MS-based proteomic analyses of SSc human skin biopsies, we identified several proteins that might be implicated in the pathogenesis and development of SSc. The most differentially expressed proteins as well as differentially expressed proteins that are involved in autoimmunity-related pathways could be considered as potential SSc biomarkers.Ã?Â?Ã? This work has received support from the EU/EFPIA/ Innovative Medicines Initiative Joint Undertaking PRECISESADS grant no 115565.www.precisesads.eu

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Paraskevi Chairta”
  • BylineArticles whose byline prints “Paschalis Nicolaou”
  • BylineArticles whose byline prints “Kleitos Sokratous”
  • BylineArticles whose byline prints “George M Spyrou”
  • BylineArticles whose byline prints “Christine Galant”
  • BylineArticles whose byline prints “Frederic Houssiau”
  • BylineArticles whose byline prints “Bernard R Lauwerys”
  • BylineArticles whose byline prints “Kyproula Christodoulou”